Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

NCT ID: NCT07033104

Last Updated: 2025-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transversalis Fascia Plane Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Transversalis fascia plane block with bupivacaine

us guided transversalis fascia plane block with bupivacaine

Group Type ACTIVE_COMPARATOR

us guided Transversalis fascia plane block

Intervention Type OTHER

addition of calcitonin to pubivacaine

Transversalis fascia plane block with calcitonin and bupivacaine

us guided transvesalis fascia plane block with calcitonin and bupivacaine

Group Type ACTIVE_COMPARATOR

us guided Transversalis fascia plane block

Intervention Type OTHER

addition of calcitonin to pubivacaine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

us guided Transversalis fascia plane block

addition of calcitonin to pubivacaine

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* female pt ASA2 scheduled for cs under spinal anesthesia

Exclusion Criteria

* patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marwa Ahmed Abogabal

Marwa Abogabal

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

tanta University hospital

Tanta, Gharbia Governorate, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

marwa ahmed Abogabal, PhD

Role: primary

+201004190210

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

36264PR1160

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.